IBI Ag, a crop protection startup developing a wide array of bio-insecticides with a lower ecological footprint, announced it has successfully closed the first part of its Series A funding round with a $6.1 million investment.
The Series A round—led by Corteva Inc., through its Corteva Catalyst platform with the participation of The Trendlines Group, Iron Nation, Consensus Business Group, and a grant from the Israel Innovation Authority.
“We are thrilled to have the support of our existing and new investors, led by Corteva through their Corteva Catalyst platform,” said Arnon Heyman, CEO of IBI Ag.
“This investment will help us to accelerate the development of our single-domain antibody technology, providing farmers with sustainable and effective crop protection solutions. We believe our single domain antibody technology is a game changer for driving agricultural productivity while preserving the environment, and the investment announced today is a significant step towards delivering this innovation to farmers across the globe,” added Arnon Heyman.
IBI-Ag is an Agri-biotech startup developing innovative and sustainable solutions for crop protection. Its technology platform utilizes nano-bodies—a type of antibody—to create effective, selective, and safe biological insect control technology that has the potential to protect the global food chain by helping farmers protect their crops with a lower ecological footprint and to transform the agricultural industry by offering an environmentally friendly and cost-effective alternative to chemical pesticides.